Monogram Biosciences has been at the forefront of individualized medicine since 1996. The company develops and commercializes innovative products to help guide and improve the treatment of infectious diseases and cancer.
We have developed HIV tests, or assays, to help make the complexities of antiretroviral therapy easier to manage.
- Health care providers use our molecular diagnostics and testing services to match the underlying molecular elements of an individual patient’s disease to the drug best able to affect those elements. This results in optimized treatment regimens for patients and reduced healthcare costs.
- Pharmaceutical companies use our services to develop new and improved antiviral therapeutics and vaccines, as well as targeted cancer therapeutics. We provide enhanced patient selection and monitoring capabilities throughout the development process.
We have also developed oncology products to help accelerate the development of targeted cancer therapeutics.
Last Updated: 11-13-06